Washington: A synthetic antibody treatment developed by Regeneron reduced the risk of developing symptomatic Covid by more than 80 percent up to eight months after receiving the treatment, the US biotech firm said Monday.
The results are "particularly important to those who do not respond to Covid-19 vaccines including people who are immunocompromised," said Myron Cohen, a University of North Carolina at Chapel Hill scientist who is leading a government-sponsored study into the treatment.
Former US president Donald Trump. — AFP NEW YORK: The judge overseeing former US president Donald Trump’s...
Bosnian Serb leader Milorad Dodik. — AFP FileSARAJEVO: The parliament of Bosnia´s autonomous Serb Republic adopted...
Australia's Prime Minister Anthony Albanese speaks during the opening ceremony of the 6th China International Import...
Indonesia's Ruang volcano. — AFP JAKARTA: Indonesia shut a provincial airport and evacuated hundreds of people...
Myanmar’s detained former leader and Aung San Suu Kyi. — AFP LONDON: Myanmar’s detained former leader and Aung...
President Ruto is seen with the chief of the Kenya Defence Forces General Francis Ogolla in this photo on 28 February....
